baber/WOPTO huggingface dataset:
Patent DK-1371474-T3 (DK)
Inventor: ZURMUEHLE WALTER
IPC: E04D15/04
Filed: 2002-07-17
Granted: 2004-05-03
Abstract: A movable carriage (2) supports a welding unit (4), drive system (11,15,16,17) and pressure application roller (11). In the welding position the carriage, apart from the drive unit and pressure application roll, is supported by a rigid guide wheel (7). During welding the guide wheel runs parallel to the edge of the upper plastic material (8) but on the overlapped lower plastic material (9).  The guide wheel (7) lies to the front of the carriage and has a narrow running surface. Adjustment of the guide wheel in the vertical direction relative to the carriage (2) raises the carriage and a following transporting roller (14). The guide wheel is mounted on a swiveling arm which can be fixed in the welding position. Alternatively the guide wheel is eccentrically mounted in relation to an axis of a swiveling arm on the carriage. An arm (5) to one side of the carriage has a steering roller (10).
Patent DK-1270725-T3 (DK)
Inventor: SKERRA ARNE
IPC: C07K14/435
Filed: 1998-09-25
Granted: 2011-05-02
Abstract: Anticalins (I) are prepared from polypeptides (II) of the lipocalin family by mutation of amino acids in the region of the 4 peptide loops (at one end of the cylindrical 'leaflet'structure). (I) can bind to a predetermined ligand with determinable affinity. An Independent claim is also included for preparation of (I).
Patent DK-1264599-T3 (DK)
Inventor: DE BAETSELIER PATRICK
IPC: A61K/
Filed: 1999-08-10
Granted: 2008-02-04
Abstract: The present invention relates to the finding that peptides derived from a specific domain of tumor necrosis factor-alpha (TNF- alpha ) can efficiently be used to treat oedema. More specifically, the present invention relates to the usage of peptides derived from the region of human TNF- alpha  from Ser<100> to Glu<116> to treat pulmonary oedema. Moreover, the present invention concerns a circularized peptide having amino acid sequence CGQRETPEGAEAKPWYC which is very efficient in inducing oedema resolution.
Patent DK-1399143-T3 (DK)
Inventor: CALVANI MENOTTI
IPC: A61P25/24
Filed: 2002-05-24
Granted: 2007-03-26
Abstract: The present invention relates to the use of an alkanoyl L-carnitine, or pharmaceutically acceptable salt thereof, for the preparation of a medicament for the treatment of anhedonia.
Patent DK-1450811-T3 (DK)
Inventor: CASTELHANO ARLINDO L
IPC: C07D487/02
Filed: 2002-11-27
Granted: 2010-02-15
Abstract: This invention pertains to compounds which specifically inhibit the adenosine A1 and A3 receptors and the use of these compounds to treat a disease associated with A3 adenosine receptor in a subject, comprising administering to the subject a therapeutically effective amount of the compounds.
Patent DK-1349422-T3 (DK)
Inventor: SCHMITT CHRISTIAN
IPC: H04R25/00
Filed: 2003-03-14
Granted: 2006-06-06
Abstract: The device has a housing lid with an opening (4) for a battery and electronic module (5) and a battery loader (1) pivotably attached to the lid by a connecting element. The battery loader covers the opening in each pivotal state so that the electronic module cannot pass through the opening and the connecting element can be removed from the lid with the loader so that the module can be passed through the opening with the loader removed.
Patent DK-1424096-T3 (DK)
Inventor: CHO JUNG-SOON
IPC: A61N1/08
Filed: 2003-11-28
Granted: 2009-10-05
Abstract: An apparatus relating to a human-body potential controlling electrotherapeutic device is disclosed herein. The device includes a power section (10) and pulse generating sections (20) for inputting prescribed high-voltage oscillating frequency signals to bipolar output sections (30). The bipolar output section can select poles according to a switching operation after amplifying and waveform-shaping the signals emitted from the pulse generating sections. Also, the device includes an operating time controlling section (40) with alarm function. Thus, the bipolar electrotherapeutic device pulses currents of positive(+) and negative(-) poles or multiple poles(+, -, +, -, +) without short circuit to allow for safe use in seeking abnormal areas in a human body to control and remove the accumulated anions and cations. <IMAGE>
Patent DK-1530719-T3 (DK)
Inventor: LIRA-CANTU MONICA M
IPC: G01N27/22
Filed: 2003-06-06
Granted: 2006-11-27
Abstract: An on-line method for determining the condition of low conductivity working fluids using alternating current, electro-impedance spectroscopy is provided by making measurements over a range of frequencies at temperatures at or above 50° C.
Patent DK-1695065-T3 (DK)
Inventor: STENBERG JOHAN
IPC: H05K1/02
Filed: 2003-12-19
Granted: 2011-12-05
Abstract: A fluid sensor is provided which contains a fluid cell (1) to enclose a volume of fluid (7), i.e., a gas or liquid, to be analyzed, in addition to a method for producing such a fluid sensor. An electromagnetic energy source (3) is arranged to transmit electromagnetic waves (4) into the fluid cell (1) with at least one detector (5) arranged to detect electromagnetic waves passing through the fluid cell (1) and at least one opening (2) situated for inlet or outlet of the fluid (7) to be analyzed. A circuit board (8, 10, 11, 12, 13, 14, 15, 16) is arranged to evaluate intensity of electromagnetic waves reaching the detector (5) and/or provide circuitry for the electromagnetic energy source (3). At least part of the fluid cell (1) is incorporated into the substrate of the circuit board (8, 10, 11, 12, 13, 14, 15, 16).
Patent DK-1636428-T3 (DK)
Inventor: SEIDL RICHARD-PETER
IPC: A01C17/00
Filed: 2004-06-17
Granted: 2007-11-05
Abstract: Disclosed are a method and a device for distributing material that is to be spread by means of a translationally moved, rotating spreading disk. According to the invention, the rotational speed of the spreading disk is boosted as the translational speed of the spreading disk increases in order to keep the spreading width of the carpet of spread material constant. The greater the spreading density, the less the rotational speed is increased. The rotational speed is increased if the spreading density drops at a steady speed in order to keep the spreading width constant. Moreover, the angle at which the material that is to be spread is discharged from the spreading disk is modified in accordance with the speed by twisting the spreading disk and/or modifying the ratio of a liquid delivered to the spreading disk along with the material that is to be spread if the speed changes while the spreading density and the spreading width are constant, the liquid ratio being reduced when the speed increases.
Patent DK-1660115-T3 (DK)
Inventor: GIANNI ALESSANDRO MASSIMO
IPC: A61K38/19
Filed: 2004-07-23
Granted: 2011-10-10
Abstract: Combined pharmaceutical preparation containing G-CSF and P1GF as the active substances, are useful in the mobilization of blood stem cells in a patient or subject in need thereof.
Patent DK-1793947-T3 (DK)
Inventor: KOLB RUDI
IPC: B21D13/02
Filed: 2004-09-09
Granted: 2009-04-14
Abstract: The invention relates to a follow-on composite tool (1), for producing a structured metal foil (4) having at least two structures (39, 41), whereby one of the two structures (39, 41) at least partially overlaps the other structure (41, 39) and the follow-on composite tool (1) consists of a tool upper part (6) and a tool lower part (7). The aim of the invention is to provide a device which allows to produce very thin, structured metal foils having a large area while meeting high quality standards. For this purpose, the follow-on composite tool (1) comprises at least three physically separate working areas (2, 5, 37), namely a punching section (37), for removing foil material in defined positions on the metal foil (4), a primary shaping section (5) for imparting the preferably undulated primary structure (41) to the metal foil (4), and a secondary shaping section (2) for imparting the preferably undulated secondary structure (46) to the metal foil (4), preferably in the area of the primary structure (41) of the metal foil (4). The invention also relates to a method for producing a structured metal foil.
Patent DK-1570901-T3 (DK)
Inventor: ROSTRUP-NIELSEN THOMAS
IPC: H01M8/06
Filed: 2005-02-07
Granted: 2008-10-13
Abstract: Process for cooling an exothermic reaction zone (5) by introducing a stream of water (3) and a hydrocarbon-containing stream (6) into a plurality of humidifying tubes (4) extending through a catalytic exothermic reaction zone (5) of a catalytic fixed bed with solid catalyst, passing the stream of water in a falling film along the inner circumference of the humidifying tubes (4), and humidifying the hydrocarbon-containing stream with water in the humidifying tubes in indirect heat exchange with the exothermic reaction zone. <IMAGE>
Patent DK-1580509-T3 (DK)
Inventor: STOECKER EDGAR
IPC: F27B7/22
Filed: 2005-03-22
Granted: 2007-12-03
Abstract: The heat-resistant protective segments (13) are formed by hollow single-piece angled bodies with hollow axial arms (15) which are mounted on support arms (14) protruding from the trailing edge of the discharge end. Cooling air (21) can flow through the arms and also through hollow noses (18) protruding inwards in the radial direction from the segment bodies. An outer tube (12) extends concentrically to and at a distance from the furnace mantle tube (10) to form a double mantle which is enclosed by heat-resistant protective segments. The noses protruding from the inner sides of the segments support the fireproof cladding. Cooling air is blown into the space inside the double mantle.
Patent DK-1768677-T3 (DK)
Inventor: BARONE DOMENICO G
IPC: A61K31/713
Filed: 2005-07-04
Granted: 2008-10-20
Abstract: The present invention relates to the use of synthetic double-stranded nucleic acid or nucleic acid analogue molecules with a bent shape structure for the prevention and treatment of pathologies induced directly or indirectly by the HMGB1 protein.
Patent DK-1695902-T3 (DK)
Inventor: CLARKSON NEIL M
IPC: B63B27/30
Filed: 2006-06-02
Granted: 2009-02-23
Abstract: A technique for stabilising a boat (2) in open water against a stationary structure (4) is disclosed. The boat (2) has a fender (8) at one end comprising a resilient material (10), and the boat (2) is urged against the structure (4) to engage the resilient material (10) with the structure (4). The frictional engagement in combination with the urging force is sufficient to prevent the engaged fender (8) from slipping down the structure (4). In this way so long as the engagement is sustained, the boat (2) is stabilised against the structure (4).
Patent DK-1833113-T3 (DK)
Inventor: KAZ TILL
IPC: H01M8/00
Filed: 2007-03-06
Granted: 2010-07-19
Abstract: Electrode-membrane-unit has a proton-conducting membrane device (18) arranged between an anode (16) and a cathode (14). The membrane device comprises a proton-conducting intermediate layer (24) to which fuel is reactable, where the intermediate layer works as a barrier layer for water flow. The proton-conducting intermediate layer is arranged between two membrane layers (20, 22), where the membrane layer (20) has a smaller thickness than the membrane layer (22).
Patent DK-2036799-T3 (DK)
Inventor: MICHAEL GANSWEIDT
IPC: B61G11/16
Filed: 2007-09-11
Granted: 2010-04-19
Abstract: A deformation tube (3) is integrated into an energy-absorbing unit (10) so that impact forces are transmitted in the longitudinal direction of the unit by a force flow from a transfer of force running through the tube and the base plate (2) and connecting plate are rigid in a longitudinal direction of the unit up to a definable amount of energy. When the definable amount of energy is exceeded, the plates are moved in the longitudinal direction by simultaneous plastic deformation of the tube. The tube is braced between the plates by a tensioning element connecting the plates.
Patent DK-2015736-T3 (DK)
Inventor: GEIGLE PETER
IPC: A61K35/12
Filed: 2007-04-27
Granted: 2011-06-14
Abstract: The present invention provides spherical microcapsules comprising at least one surface coating and a core, wherein the at least one surface coating comprises cross-linked polymers, and wherein the core comprises cross-linked polymers and cells capable of expressing and secreting a GLP-1 peptide, a fragment or variant thereof or a fusion peptide comprising GLP-1 or a fragment or variant thereof. The present application is furthermore directed to methods for production of these spherical microcapsules and to the use of these microcapules e.g. in the treatment of type 2 diabetes, weight disorders and diseases or conditions associated thereto, neurodegenerative disorders and diseases or conditions associated thereto, or for the treatment of disorders and diseases or conditions associated to apoptosis.
Patent DK-2073956-T3 (DK)
Inventor: LOEHNERT HORST
IPC: B24D15/08
Filed: 2007-08-31
Granted: 2010-10-11
Abstract: Fitted on each side of a guide slot (6), main moving sharpening rods (10a,10b) cross at an intersecting point (11) in the area of the guide slot and operate swiveling movements (14a,14b) against a flexible springy restoring force when a knife blade is inserted. There are also fixed elements (7a,7b) for preliminary sharpening in a longitudinal section of the guide slot.
Patent DK-1967739-T3 (DK)
Inventor: ANNEBIQUE ANDRE
IPC: F04D27/02
Filed: 2008-02-15
Granted: 2011-03-07
Abstract: The device has a displacement cylinder (6) with a piston (7) between first and second chambers (11, 12) connected by control oil lines to a 4-way valve. Feed and return control oil lines are each divided into two parallel branches, two redundant 4-way valves are arranged in the parallel branches and seat valves are arranged between the connections (14,15) and the 4-way valves.
Patent DK-2056463-T3 (DK)
Inventor: TAYLOR MATTHEW PAUL ATHOL
IPC: H03M13/27
Filed: 2008-10-15
Granted: 2014-01-27
Abstract: A data processing apparatus is arranged to map input data symbols to be communicated onto a predetermined number of sub-carrier signals of Orthogonal Frequency Division Multiplexed OFDM symbols. The predetermined number of sub-carrier signals is determined in accordance with one of a plurality of operating modes and the input data symbols are divided into first sets of input data symbols and second sets of input data symbols. The data processing apparatus comprises an interleaver operable to perform an odd interleaving process which interleaves the first sets of input data symbols on to the sub-carrier signals of first OFDM symbols and an even interleaving process which interleaves the second sets of input data symbols on to the sub-carrier signals of second OFDM symbols, such that while the input data symbols from the first set are being read from locations in the interleaver memory, input data symbols from the second set can be written to the locations just read from and when input data symbols from the second set are being read from the locations in the interleaver memory, the input data symbols from a following first set can be written to the locations just read from. Furthermore, when the number data symbols which can be carried by the sub-carriers of an OFDM symbol in one of the plurality of operating modes is half or less than half of the number of data symbols, which can be carried in an operating mode which provides the most number of data bearing sub-carrier signals per OFDM symbol, the data processing apparatus is operable to interleave the input data symbols from both first and second sets in accordance with the odd interleaving process on to the first and second OFDM symbols, and to change the permutation code which is used to form the addresses from one OFDM symbol to another.
Patent DK-2145775-T3 (DK)
Inventor: PHELY OLIVIER
IPC: B60C7/12
Filed: 2009-07-07
Granted: 2010-12-20
Abstract: The tire (14) has a casing comprising an inner wall (42) for surrounding convex outer walls (34a, 34b) of a peripheral seat (22) and provided with a retaining bead (52). The bead is received in a peripheral slot (26) in the seat. A convex outer wall (44) of the casing forms a tread of the tire. The inner wall is concave so as to surmount the convex outer walls of the seat. The inner wall and the outer wall of the casing are connected by two annular borders (46, 48). The borders cover the outer walls of the seat in a direction of a hub (16), where the hub is surrounded with the seat. An independent claim is also included for a wheel rim formed of a hub surrounded with a peripheral seat.
Patent DK-2187712-T3 (DK)
Inventor: ROSTOKER NORMAN
IPC: H05H1/16
Filed: 2002-02-01
Granted: 2015-08-31
Abstract: A system and method for containing plasma and forming a Field Reversed Configuration (FRC) magnetic topology are described in which plasma ions are contained magnetically in stable, non-adiabatic orbits in the FRC. Further, the electrons are contained electrostatically in a deep energy well, created by tuning an externally applied magnetic field. The simultaneous electrostatic confinement of electrons and magnetic confinement of ions avoids anomalous transport and facilitates classical containment of both electrons and ions. In this configuration, ions and electrons may have adequate density and temperature so that upon collisions they are fused together by nuclear force, thus releasing fusion energy. Moreover, the fusion fuel plasmas that can be used with the present confinement system and method are not limited to neutronic fuels only, but also advantageously include advanced fuels.
Patent DK-2484346-T3 (DK)
Inventor: MATTHEWS FRANK
IPC: A61K9/50
Filed: 2007-06-19
Granted: 2017-04-24
Abstract: Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided.
Patent DK-2788054-T3 (DK)
Inventor: SHETTY GAUTAM N
IPC: A61M5/315
Filed: 2012-12-06
Granted: 2018-08-06
Abstract: A dose control mechanism for a syringe includes a plunger having a coarse pitch screw on its exterior surface, a housing having a corresponding coarse pitch guide along the interior surface of the housing, a screw having a fine pitch screw which interfaces with a fine pitch nut of an adapter, wherein the plunger has an internal annular space within which screw at least partially resides. An accurate dose drug delivery syringe includes such a dose control mechanism, a barrel, a plunger seal, and a barrel adapter assembly having a barrel tip and a needle. The syringe may be a fill-at-time-of-use syringe, a pre-filled syringe, or a safety syringe having integrated needle retraction or needle sheathing safety features, or a combination thereof. Methods of assembly, manufacturing, and operation are similarly disclosed.
Patent DK-2772261-T3 (DK)
Inventor: NISHIWAKI YASUMI
IPC: C01B32/336
Filed: 2012-10-05
Granted: 2018-01-08
Abstract: The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or removal performance, whereby a toxic substance inside the body can be adsorbed or removed rapidly and in large quantity. The present invention is an orally administered adsorbent comprising activated carbon fiber, wherein the orally administered adsorbent is a drug for treating or preventing kidney disease, or a drug for treating or preventing dialysis complications.
Patent DK-2864328-T3 (DK)
Inventor: BLAGG JULIAN
IPC: C07D471/06
Filed: 2013-06-21
Granted: 2018-03-12
Abstract: The present invention relates to compounds of formula I: wherein R1 and R2 are as defined herein, or a pharmaceutically acceptable salt or solvate thereof. The compounds of formula I are inhibitors of aurora kinase and/or FLT3. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which aurora kinase and/or FLT3 activity is implicated.
Patent DK-2821049-T3 (DK)
Inventor: KAVAZOV JULIAN D
IPC: A61J1/20
Filed: 2008-11-03
Granted: 2018-03-26
Abstract: Various embodiments of the present invention are directed to transferring fluidic media from a vial to a reservoir. In various embodiments, fluidic media may be transferred from the vial to the reservoir by moving a housing portion to move a plunger head located in the reservoir to draw fluidic media from the vial to the reservoir. In other embodiments, fluidic media may be transferred from the vial to the reservoir while the reservoir is held by a holding unit and vibrated by a vibrator to remove air from the fluidic media. In some embodiments, fluidic media may be transferred from the vial to the reservoir by moving a handle operatively connected to a bias member for assisting with the transfer of fluidic media. In other embodiments, the transfer of fluidic media may be assisted by a bias member and a needle connecting atmosphere and the vial.
Patent DK-0423692-T3 (DK)
Inventor: SARUP BENT
IPC: C07C47/02
Filed: 1990-10-15
Granted: 1996-09-09
Abstract: An improved catalyst for the conversion of an alcohol to an aldehyde by partial oxidation of the alcohol comprises active catalytic material with a monolithic structured inert carrier. The active catalytic material comrpises a mixt. of the oxides of molybdenum plus M in molar ratio Mo: M between 1 and 5, where M = chromium, vanadium, aluminum, iron, tungsten or manganese. The carrier has straight channels through the structure of a cross corrugated structure. The carrier consists of silica rich fibres and may be reinforced by a binder. The active material constitutes 1-90 wt.% of the catalyst. The reaction is carried out in a wall cooled reactor, or an adiabatic reactor or both.
Patent DK-0487774-T3 (DK)
Inventor: LANG SIEGFRIED DR
IPC: A61K9/20
Filed: 1990-11-29
Granted: 1994-11-21
Abstract: A direct tabletting auxiliary contains, in an intimate mixture, the essential components   A) from 60 to 98% by weight, based on the direct tabletting auxiliary, of microcrystalline cellulose, cornstarch, mannitol, lactose, sorbitol, cellulose powder, calcium sulfate, calciuöm phosphate, calcium carbonate, sodium starch glycolate or calcium carboxymethyl cellulose, B) from 2 to 40% by weight, based on the direct tabletting auxiliary, of a binder selected from the group comprising hydroxypropylmethylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, methylcellulose, pregelatinized starch maltodextrin, polyvinylpyrrolidone, gelatin and  alpha -,  beta - or gamma -cyclodextrin, where the intimate mixture of A and B has been produced in the presence of water using a wet mixing process and simultaneous or subsequent drying. t
Patent DK-0431561-T3 (DK)
Inventor: WYNBERG HANS
IPC: C07C237/44
Filed: 1990-12-04
Granted: 1995-02-01
Abstract: Metoclopramide, or suitable salt thereof, is demethylated with pyridinium hydrochloride, providing an intermediate to quinuclidinyl benzamide drugs.
Patent DK-0453656-T3 (DK)
Inventor: CALL HANS-PETER DR
IPC: C12N9/24
Filed: 1990-12-22
Granted: 1996-05-28
Abstract: PCT No. PCT/EP91/00712 Sec. 371 Date Oct. 20, 1992 Sec. 102(e) Date Oct. 20, 1992 PCT Filed Apr. 15, 1991 PCT Pub. No. WO91/16414 PCT Pub. Date Oct. 31, 1991.A process for the production of lignolytical enzymes using Phanerochaete chrysosporium which includes placing a culture of the pocket rot fungus Phanerochaete chrysosporium into a closed fermentation vessel which has no stirring mechanism. Pellets of Phanerochaete chrysosporium are produced in the vessel by rotating and slewing the vessel, and enzyme is then harvested. An apparatus for carrying out the process includes a cardanic mount for freely rotatably and slewably suspending the vessel.